Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 2/2013

01-02-2013 | 2012 SSAT Poster Presentation

Overweight Patients Operated on for Cancer of the Esophagus Survive Longer than Normal-Weight Patients

Authors: Marco Scarpa, Matteo Cagol, Silvia Bettini, Rita Alfieri, Amedeo Carraro, Francesco Cavallin, Elisabetta Trevellin, Luca M. Saadeh, Alberto Ruol, Roberto Vettor, Ermanno Ancona, Carlo Castoro

Published in: Journal of Gastrointestinal Surgery | Issue 2/2013

Login to get access

Abstract

Background

Esophageal adenocarcinoma is often associated with obesity, and a 5 Kg m−2 increase in body mass index (BMI) has, in fact, been found to be strongly associated with the risk of this type of cancer (RR, 1.52; p < 0.0001). Esophagectomy with lymphoadenectomy is the mainstay of therapy for these patients. The aim of this study was to assess and compare the surgical and oncological outcomes as well as the survival rates of underweight, normal weight, overweight, and obese patients following esophagectomy for esophageal cancer.

Patients and Methods

Data relative to 1,127 patients with esophageal adenocarcinoma presenting at a specialized tertiary hospital (the Center of Esophageal Diseases for the Veneto Region) between 2000 and 2008 were prospectively collected. The 278 subjects whose BMI values before disease onset were available and underwent esophagectomy were enrolled in the study. Sixty-one of the 278 patients were classified as obese (BMI >30), 121 were classified as overweight (BMI, 25–29.9), 81 were classified as normal weight (BMI <24.9), and 15 ones as underweight (BMI <20). The outcome and survival of the four groups were compared. Frequency and survival analyses were carried out.

Results

The rate of R0 esophagectomy and the incidence of toxicity during neoadjuvant chemotherapy were similar in the four groups. Respiratory complications after R0 esophagectomy seemed to be more frequent in the underweight and normal-weight patients group (p < 0.01). Moreover, underweight patients had a significantly higher rate of septic, cardiovascular, and metabolic postoperative complications. The 121 overweight patients had a better overall survival rate compared to normal weight and obese patients (p = 0.05). This difference was not significant if patients were stratified in stages I or II or stages III or IV.

Conclusion

Overweight patients seem to respond better to esophageal cancer and esophagectomy with respect to normal-weight ones. This data seem to suggest that in spite of several unfavorable features, a moderate increase of weight may be helpful to survive after esophagectomy for cancer.
Literature
1.
2.
go back to reference Refaely Y, Krasna MJ: Multimodality therapy for esophageal cancer. Surg Clin North Am 82:729–746, 2002PubMedCrossRef Refaely Y, Krasna MJ: Multimodality therapy for esophageal cancer. Surg Clin North Am 82:729–746, 2002PubMedCrossRef
3.
go back to reference Ogden CL, Carroll MD, Curtin LR et al. (2006) Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 295:1549–1555PubMedCrossRef Ogden CL, Carroll MD, Curtin LR et al. (2006) Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 295:1549–1555PubMedCrossRef
4.
go back to reference Williamson DF (1993) Descriptive epidemiology of body weight and weight change in U.S. adults. Ann Intern Med 119:646–649PubMed Williamson DF (1993) Descriptive epidemiology of body weight and weight change in U.S. adults. Ann Intern Med 119:646–649PubMed
5.
go back to reference Calle E, Rodriguez C, Walker-Thurmund K, Thun M. Overweight, obesity and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med. 2003;348:1625–38.PubMedCrossRef Calle E, Rodriguez C, Walker-Thurmund K, Thun M. Overweight, obesity and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med. 2003;348:1625–38.PubMedCrossRef
7.
go back to reference De Vita F, Di Martino N, Orditura M, Cosenza A, Galizia G, Del Genio A, Catalano G. Preoperative chemoradiotherapy for squamous cell carcinoma and adenocarcinoma of the esophagus: a phase II study. Chest. 2002 Oct;122(4):1302–8.PubMedCrossRef De Vita F, Di Martino N, Orditura M, Cosenza A, Galizia G, Del Genio A, Catalano G. Preoperative chemoradiotherapy for squamous cell carcinoma and adenocarcinoma of the esophagus: a phase II study. Chest. 2002 Oct;122(4):1302–8.PubMedCrossRef
8.
go back to reference Wu PC, Posner MC. The role of surgery in the management of oesophageal cancer. Lancet Oncol 2003;4:481–488.PubMedCrossRef Wu PC, Posner MC. The role of surgery in the management of oesophageal cancer. Lancet Oncol 2003;4:481–488.PubMedCrossRef
9.
go back to reference Jamieson GG, Mathew G, Ludemann R, et al. Postoperative mortality following oesophagectomy and problems in reporting its rate. Br J Surg 2004;91:943–947.PubMedCrossRef Jamieson GG, Mathew G, Ludemann R, et al. Postoperative mortality following oesophagectomy and problems in reporting its rate. Br J Surg 2004;91:943–947.PubMedCrossRef
10.
go back to reference Viklund P, Lindblad M, Lu M, Ye W, Johansson J, Lagergren J. Risk factors for complications after esophageal cancer resection: a prospective population-based study in Sweden. Ann Surg. 2006; 243(2):204–1.PubMedCrossRef Viklund P, Lindblad M, Lu M, Ye W, Johansson J, Lagergren J. Risk factors for complications after esophageal cancer resection: a prospective population-based study in Sweden. Ann Surg. 2006; 243(2):204–1.PubMedCrossRef
11.
go back to reference Dindo D, Muller MK, Weber M, Clavien PA Obesity in general elective surgery. Lancet (2003) 361:2032–2035PubMedCrossRef Dindo D, Muller MK, Weber M, Clavien PA Obesity in general elective surgery. Lancet (2003) 361:2032–2035PubMedCrossRef
12.
13.
14.
go back to reference Healy LA, Ryan AM, Gopinath B et al. Impact of obesity on outcomes in the management of localized adenocarcinoma of the esophagus and esophagogastric junction. J Thorac Cardiovasc Surg (2007) 134:1284–1291PubMedCrossRef Healy LA, Ryan AM, Gopinath B et al. Impact of obesity on outcomes in the management of localized adenocarcinoma of the esophagus and esophagogastric junction. J Thorac Cardiovasc Surg (2007) 134:1284–1291PubMedCrossRef
15.
go back to reference Mullen JT, Davenport DL, Hutter MM et al. Impact of body mass index on perioperative outcomes in patients undergoing major intra-abdominal cancer surgery. Ann Surg Oncol (2008) 15:2164–2172PubMedCrossRef Mullen JT, Davenport DL, Hutter MM et al. Impact of body mass index on perioperative outcomes in patients undergoing major intra-abdominal cancer surgery. Ann Surg Oncol (2008) 15:2164–2172PubMedCrossRef
16.
go back to reference Yoon HH, Lewis MA, Shi Q, Khan M, Cassivi SD, Diasio RB, Sinicrope FA. Prognostic impact of body mass index stratified by smoking status in patients with esophageal adenocarcinoma. J Clin Oncol. 2011 Dec 1;29(34):4561–7.PubMedCrossRef Yoon HH, Lewis MA, Shi Q, Khan M, Cassivi SD, Diasio RB, Sinicrope FA. Prognostic impact of body mass index stratified by smoking status in patients with esophageal adenocarcinoma. J Clin Oncol. 2011 Dec 1;29(34):4561–7.PubMedCrossRef
17.
go back to reference Melis M, Weber JM, McLoughlin JM, Siegel EM, Hoffe S, Shridhar R, Turaga KK, Dittrick G, Dean EM, Karl RC, Meredith KL. An elevated body mass index does not reduce survival after esophagectomy for cancer. Ann Surg Oncol. 2011 Mar;18(3):824–31.PubMedCrossRef Melis M, Weber JM, McLoughlin JM, Siegel EM, Hoffe S, Shridhar R, Turaga KK, Dittrick G, Dean EM, Karl RC, Meredith KL. An elevated body mass index does not reduce survival after esophagectomy for cancer. Ann Surg Oncol. 2011 Mar;18(3):824–31.PubMedCrossRef
18.
go back to reference Grotenhuis BA, Wijnhoven BP, Hötte GJ, van der Stok EP, Tilanus HW, van Lanschot JJ. Prognostic value of body mass index on short-term and long-term outcome after resection of esophageal cancer. World J Surg. 2010 Nov;34(11):2621–7.PubMedCrossRef Grotenhuis BA, Wijnhoven BP, Hötte GJ, van der Stok EP, Tilanus HW, van Lanschot JJ. Prognostic value of body mass index on short-term and long-term outcome after resection of esophageal cancer. World J Surg. 2010 Nov;34(11):2621–7.PubMedCrossRef
19.
go back to reference Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (Eds.) (2009) AJCC cancer staging manual 7th edition. New York: Springer Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (Eds.) (2009) AJCC cancer staging manual 7th edition. New York: Springer
20.
go back to reference Ruol A, Portale G, Castoro C, Merigliano S, Cavallin F, Battaglia G, Michieletto S, Ancona E. Management of esophageal cancer in patients aged over 80 years. Eur J Cardiothorac Surg. 2007 Sep;32(3):445–8. Epub 2007 Jul 23.PubMedCrossRef Ruol A, Portale G, Castoro C, Merigliano S, Cavallin F, Battaglia G, Michieletto S, Ancona E. Management of esophageal cancer in patients aged over 80 years. Eur J Cardiothorac Surg. 2007 Sep;32(3):445–8. Epub 2007 Jul 23.PubMedCrossRef
21.
go back to reference Ancona E, Ruol A, Santi S, Merigliano S, Sileni VC, Koussis H, Zaninotto G, Bonavina L, Peracchia A. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone. Cancer. 2001 Jun 1;91(11):2165–74.PubMedCrossRef Ancona E, Ruol A, Santi S, Merigliano S, Sileni VC, Koussis H, Zaninotto G, Bonavina L, Peracchia A. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone. Cancer. 2001 Jun 1;91(11):2165–74.PubMedCrossRef
22.
go back to reference Abnet CC, Freedman ND, Hollenbeck AR, Fraumeni JF, Leitzmann M, Schatzkin A. A prospective study of BMI and risk of esophageal and gastric adenocarcinoma. Eur J Cancer. 2008 February; 44(3): 465–471.PubMedCrossRef Abnet CC, Freedman ND, Hollenbeck AR, Fraumeni JF, Leitzmann M, Schatzkin A. A prospective study of BMI and risk of esophageal and gastric adenocarcinoma. Eur J Cancer. 2008 February; 44(3): 465–471.PubMedCrossRef
23.
go back to reference Beddy P, Howard J, McMahon C, Knox M, de Blacam C, Ravi N, Reynolds J V, Keogan MT. Association of visceral adiposity with oesophageal and junctional adenocarcinomas Br J Surg 2010; 97: 1028–1034PubMedCrossRef Beddy P, Howard J, McMahon C, Knox M, de Blacam C, Ravi N, Reynolds J V, Keogan MT. Association of visceral adiposity with oesophageal and junctional adenocarcinomas Br J Surg 2010; 97: 1028–1034PubMedCrossRef
24.
go back to reference van Kruijsdijk RCM, van der Wall E, Visseren FL.J. Obesity and Cancer: The Role of Dysfunctional Adipose Tissue. Cancer Epidemiol Biomarkers Prev 2009;18(10): 2569–2578PubMedCrossRef van Kruijsdijk RCM, van der Wall E, Visseren FL.J. Obesity and Cancer: The Role of Dysfunctional Adipose Tissue. Cancer Epidemiol Biomarkers Prev 2009;18(10): 2569–2578PubMedCrossRef
25.
go back to reference Howard JM, Beddy P, Ennis D, Keogan M, Pidgeon GP, Reynolds JV. Associations between leptin and adiponectin receptor upregulation, visceral obesity and tumour stage in oesophageal and junctional adenocarcinoma Br J Surg 2010; 97: 1020–1027PubMedCrossRef Howard JM, Beddy P, Ennis D, Keogan M, Pidgeon GP, Reynolds JV. Associations between leptin and adiponectin receptor upregulation, visceral obesity and tumour stage in oesophageal and junctional adenocarcinoma Br J Surg 2010; 97: 1020–1027PubMedCrossRef
26.
go back to reference Ouattara M, D’Journo XB, Loundou A, Trousse D, Dahan L, Doddoli C, Seitz JF, Thomas PA (2012) Body mass index kinetics and risk factors of malnutrition one year after radical oesophagectomy for cancer. Eur J Cardiothorac Surg 41(5):1088–1093PubMedCrossRef Ouattara M, D’Journo XB, Loundou A, Trousse D, Dahan L, Doddoli C, Seitz JF, Thomas PA (2012) Body mass index kinetics and risk factors of malnutrition one year after radical oesophagectomy for cancer. Eur J Cardiothorac Surg 41(5):1088–1093PubMedCrossRef
27.
go back to reference Chandra RK. Impact of nutritional status and nutrient supplements on immune responses and incidence of infection in older individuals Ageing Research Reviews 3 (2004) 91–104PubMedCrossRef Chandra RK. Impact of nutritional status and nutrient supplements on immune responses and incidence of infection in older individuals Ageing Research Reviews 3 (2004) 91–104PubMedCrossRef
28.
go back to reference Long KZ, Nanhakumar N. Energetic and nutritional regulation of the adaptive immune response and trade-offs in ecological immunology. Am J Hum Biol 16:499–507 (2004)PubMedCrossRef Long KZ, Nanhakumar N. Energetic and nutritional regulation of the adaptive immune response and trade-offs in ecological immunology. Am J Hum Biol 16:499–507 (2004)PubMedCrossRef
29.
go back to reference Shuji Ogino, Jérôme Galon, Charles S. Fuchs and Glenn Dranoff. Cancer immunology-analysis of host and tumor factors for personalized medicine. Nat. Rev. Clin. Oncol. 8, 711–719 (2011) Shuji Ogino, Jérôme Galon, Charles S. Fuchs and Glenn Dranoff. Cancer immunology-analysis of host and tumor factors for personalized medicine. Nat. Rev. Clin. Oncol. 8, 711–719 (2011)
30.
go back to reference Healy L, Ryan A, Gopinath B, Rowley S, Byrne P, Reynolds J. Impact of obesity on outcomes in the management of localized adenocarcinoma of the esophagus and esophagogastric junction. J Thorac Cardiovasc Surg. 2007;134:1284–91.PubMedCrossRef Healy L, Ryan A, Gopinath B, Rowley S, Byrne P, Reynolds J. Impact of obesity on outcomes in the management of localized adenocarcinoma of the esophagus and esophagogastric junction. J Thorac Cardiovasc Surg. 2007;134:1284–91.PubMedCrossRef
31.
go back to reference Morgan MA, Lewis WG, Hopper AN, et al. Prognostic significance of body mass indices for patients undergoing esophagectomy for cancer. Dis Esophagus. 2007;20:29–35.PubMedCrossRef Morgan MA, Lewis WG, Hopper AN, et al. Prognostic significance of body mass indices for patients undergoing esophagectomy for cancer. Dis Esophagus. 2007;20:29–35.PubMedCrossRef
Metadata
Title
Overweight Patients Operated on for Cancer of the Esophagus Survive Longer than Normal-Weight Patients
Authors
Marco Scarpa
Matteo Cagol
Silvia Bettini
Rita Alfieri
Amedeo Carraro
Francesco Cavallin
Elisabetta Trevellin
Luca M. Saadeh
Alberto Ruol
Roberto Vettor
Ermanno Ancona
Carlo Castoro
Publication date
01-02-2013
Publisher
Springer-Verlag
Published in
Journal of Gastrointestinal Surgery / Issue 2/2013
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-012-2023-2

Other articles of this Issue 2/2013

Journal of Gastrointestinal Surgery 2/2013 Go to the issue